Kind

Treatments

Interventions described in the published literature.

• Treatment

  Azithromycin

  Evidence: small uncontrolled human study (abstract only); guideline abstract only; registry entries

  A macrolide antibiotic that appears in the BOS literature, in a small uncontrolled study, in a guideline abstract and in registered trials.

• Treatment

  Belumosudil

  Evidence: registry descriptions only; investigational; no results posted

  A drug tested as the study intervention in two registered CLAD trials (ROCKaspire and CTOT-47); no results are posted for either.

• Treatment

  Extracorporeal photopheresis (ECP)

  Evidence: registry descriptions only; no efficacy source read

  A procedure described in registry entries as used for CLAD and BOS and studied in registered trials; no efficacy source was read.

• Treatment

  Retransplantation

  Evidence: guideline abstract only; retrospective multicentre cohort (abstract only)

  Repeat lung transplantation, named in the 2014 BOS guideline abstract and studied in a multicentre cohort by CLAD phenotype.